Julie McElrath
#54,118
Most Influential Person Now
HIV researcher
Julie McElrath's AcademicInfluence.com Rankings
Julie McElrathbiology Degrees
Biology
#4729
World Rank
#7024
Historical Rank
Immunology
#330
World Rank
#343
Historical Rank
Julie McElrathphilosophy Degrees
Philosophy
#5604
World Rank
#8451
Historical Rank
Logic
#2977
World Rank
#4065
Historical Rank
Download Badge
Biology Philosophy
Julie McElrath's Degrees
- Bachelors Biology Stanford University
- Doctorate Medicine University of California, San Francisco
- PhD Immunology University of Washington
Similar Degrees You Can Earn
Why Is Julie McElrath Influential?
(Suggest an Edit or Addition)According to Wikipedia, M. Juliana “Julie” McElrath is a senior vice president and director of the vaccine and infection disease division at Fred Hutchinson Cancer Research Center and the principal investigator of the HIV Vaccine Trials Network Laboratory Center in Seattle, Washington. She is also a professor at the University of Washington.
Julie McElrath's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Integrated analysis of multimodal single-cell data (2020) (2815)
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial (2008) (1743)
- Immune-correlates analysis of an HIV-1 vaccine efficacy trial. (2012) (1506)
- The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation (2010) (1129)
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine (2021) (813)
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis (2008) (750)
- Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. (1997) (586)
- Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. (2013) (536)
- Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1 (2007) (514)
- Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. (1996) (479)
- Setting the stage: host invasion by HIV (2008) (460)
- mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (2021) (392)
- HIV-1 Integration Landscape during Latent and Active Infection (2015) (375)
- A Blueprint for HIV Vaccine Discovery. (2012) (372)
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation (2020) (350)
- Origin and differentiation of human memory CD8 T cells after vaccination (2017) (326)
- Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. (2011) (310)
- Induction of immunity to human immunodeficiency virus type-1 by vaccination. (2010) (293)
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology (2015) (286)
- Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. (2010) (257)
- HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1 (2016) (257)
- Homologous and Heterologous Covid-19 Booster Vaccinations (2022) (241)
- CXCL13 is a plasma biomarker of germinal center activity (2016) (240)
- Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. (1997) (239)
- Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial. (2016) (232)
- Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial (2011) (229)
- Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. (2007) (229)
- Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. (1989) (221)
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) (2018) (214)
- Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. (2007) (214)
- Protective HIV-specific CD8+ T cells evade Treg cell suppression (2011) (212)
- Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells (2021) (209)
- COMPASS identifies T-cell subsets correlated with clinical outcomes (2015) (207)
- Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response (2009) (207)
- Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. (1998) (201)
- Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. (1993) (195)
- A framework for assessing immunological correlates of protection in vaccine trials. (2007) (192)
- Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. (1989) (184)
- A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. (1999) (180)
- Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies (2015) (179)
- HIV-1 Induces Cytotoxic T Lymphocytes in the Cervix of Infected Women (1997) (179)
- T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant (2019) (176)
- Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection. (2000) (172)
- Comprehensive Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Secreting CD8+ T Cells in Primary HIV-1 Infection (2003) (171)
- Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. (1999) (166)
- COVID-19 and the Path to Immunity. (2020) (154)
- Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity (2012) (152)
- The dynamics of granuloma formation in experimental visceral leishmaniasis (1988) (149)
- A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204) (2011) (148)
- Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. (2021) (148)
- Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses (1997) (146)
- Evolution of CD8+ T Cell Immunity and Viral Escape Following Acute HIV-1 Infection1 (2003) (143)
- QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. (2001) (141)
- Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection (2006) (136)
- Human Immunodeficiency Virus Type 1 Mediates Global Disruption of Innate Antiviral Signaling and Immune Defenses within Infected Cells (2009) (135)
- Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. (2012) (134)
- Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. (2004) (133)
- Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. (1999) (133)
- Preservation of T Cell Proliferation Restricted by Protective HLA Alleles Is Critical for Immune Control of HIV-1 Infection1 (2006) (128)
- Dynamics of the Cytotoxic T Cell Response to a Model of Acute Viral Infection (2015) (127)
- Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. (2001) (122)
- Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells (2021) (119)
- Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 Infection (2006) (116)
- Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120: Negative Results Fail to Trigger a Phase 3 Correlates Trial (2007) (115)
- Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. (2003) (115)
- Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. (1991) (112)
- Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. (2014) (109)
- Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). (2013) (109)
- Innate Immune Signaling Induces High Levels of TC-specific Deaminase Activity in Primary Monocyte-derived Cells through Expression of APOBEC3A Isoforms* (2010) (106)
- Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation. (2006) (105)
- Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with ⩾400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients (1997) (103)
- Distinct activation thresholds of human conventional and innate-like memory T cells. (2016) (100)
- Combined Effect of CCR5-Δ32 Heterozygosity and the CCR5 Promoter Polymorphism −2459 A/G on CCR5 Expression and Resistance to Human Immunodeficiency Virus Type 1 Transmission (2005) (100)
- Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. (2007) (100)
- FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. (2014) (99)
- Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. (2003) (98)
- A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection (2017) (96)
- Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals (2003) (95)
- Vaginal Langerhans Cells Nonproductively Transporting HIV-1 Mediate Infection of T Cells (2011) (94)
- Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes (2011) (92)
- An Antibody Targeting the Fusion Machinery Neutralizes Dual‐Tropic Infection and Defines a Site of Vulnerability on Epstein‐Barr Virus (2018) (92)
- Safety and Immunogenicity of a High‐Titered Canarypox Vaccine in Combination With rgp120 in a Diverse Population of HIV‐1‐Uninfected Adults: AIDS Vaccine Evaluation Group Protocol 022A (2002) (91)
- Vaccination establishes clonal relatives of germinal center T cells in the blood of humans (2017) (91)
- Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype. (1999) (91)
- Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape (2007) (89)
- Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. (2014) (89)
- Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. (1998) (89)
- Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report (2021) (86)
- Selection of potent immunological adjuvants for vaccine construction. (1995) (86)
- Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3. (1998) (86)
- Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals (2009) (86)
- A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers. (2011) (85)
- Dendritic Cell–T-Cell Interactions Support Coreceptor-Independent Human Immunodeficiency Virus Type 1 Transmission in the Human Genital Tract (1999) (85)
- Safety and Immunogenicity of a Candidate HIV-1 Vaccine in Healthy Adults: Recombinant Glycoprotein (rgp) 120: A Randomized, Double-Blind Trial (1996) (84)
- Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials (2017) (83)
- HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly (2012) (83)
- Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection (1993) (82)
- Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group. (1997) (81)
- Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual (2020) (80)
- Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120/MF59 in Adults (2021) (79)
- Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization (2016) (78)
- Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. (2014) (77)
- Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+ T Cells Induced by Different Adenovirus Vectors (2012) (77)
- Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial (2020) (77)
- Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure (2011) (76)
- Cytotoxic T Cell and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Envelope with a Combination Vaccine Regimen (1998) (75)
- Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial (2018) (74)
- Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection (2011) (74)
- Safety and Immunogenicity of Env 2-3, a Human Immunodeficiency Virus Type 1 Candidate Vaccine, in Combination with a Novel Adjuvant, MTP-PE/MF59 (1996) (73)
- Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. (2013) (71)
- Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. (1987) (69)
- Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120. (2001) (69)
- Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope (2019) (69)
- Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network. (1994) (68)
- Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study (2011) (68)
- Vpu Mediates Depletion of Interferon Regulatory Factor 3 during HIV Infection by a Lysosome-Dependent Mechanism (2012) (68)
- A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection (2000) (67)
- High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. (2005) (67)
- Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. (2016) (66)
- Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. (2019) (66)
- Virus-Specific CD8+ T-Cell Responses Better Define HIV Disease Progression than HLA Genotype (2010) (66)
- Comparison of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses in HIV-1- and HIV-2-Infected Individuals in Senegal (2004) (64)
- Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization (2009) (63)
- Ontogeny and Specificities of Mucosal and Blood Human Immunodeficiency Virus Type 1-Specific CD8+ Cytotoxic T Lymphocytes (2003) (61)
- Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines. (2004) (61)
- Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28. (2011) (61)
- Challenges and responses in human vaccine development. (2014) (61)
- Comprehensive Assessment of HIV Target Cells in the Distal Human Gut Suggests Increasing HIV Susceptibility Toward the Anus (2013) (60)
- Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial. (2009) (59)
- Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity (2010) (58)
- Defining the risk of SARS-CoV-2 variants on immune protection (2022) (58)
- Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial (2017) (57)
- Post-step modifications for research on HIV vaccines. (2009) (57)
- HIV-DNA Priming Alters T Cell Responses to HIV-Adenovirus Vaccine Even When Responses to DNA Are Undetectable (2011) (56)
- Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. (2004) (56)
- Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice (1987) (56)
- Mucosal effects of tenofovir 1% gel (2014) (55)
- A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects. (2011) (54)
- Enhanced Detection of Human Immunodeficiency Virus Type 1 (HIV-1) Nef-Specific T Cells Recognizing Multiple Variants in Early HIV-1 Infection (2007) (53)
- Polyinosinic-Polycytidylic Acid Is the Most Effective TLR Adjuvant for SIV Gag Protein–Induced T Cell Responses In Nonhuman Primates (2013) (53)
- Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial (2014) (53)
- Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054) (2010) (53)
- Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells 1 (2003) (52)
- Abacavir hypersensitivity reaction in primary HIV infection (2006) (52)
- Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. (2006) (51)
- Macaques Infected with a CCR5-Tropic Simian/Human Immunodeficiency Virus (SHIV) Develop Broadly Reactive Anti-HIV Neutralizing Antibodies (2007) (51)
- Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial. (1998) (51)
- Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies (2010) (50)
- Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting. (1994) (49)
- Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples. (2015) (49)
- Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen. (1996) (49)
- Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects (2021) (48)
- Optimizing Viable Leukocyte Sampling from the Female Genital Tract for Clinical Trials: An International Multi-Site Study (2014) (48)
- Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses (2015) (47)
- CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells (2019) (47)
- Evolution of HIV-1 CTL epitopes: Fitness-Balanced Escape (2007) (47)
- Use of adenovirus type-5 vectored vaccines: a cautionary tale (2020) (46)
- HIV-1 Vaccination Administered Intramuscularly Can Induce Both Systemic and Mucosal T Cell Immunity in HIV-1-Uninfected Individuals (2003) (46)
- Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214. (2000) (46)
- HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition (2015) (45)
- Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120 (2017) (45)
- Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1 (2021) (45)
- Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses. (2009) (44)
- Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial (2011) (44)
- Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates (2015) (44)
- Early Induction and Maintenance of Env-Specific T-Helper Cells following Human Immunodeficiency Virus Type 1 Infection (2003) (44)
- Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women. (1999) (44)
- Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories (2010) (43)
- Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials. (2013) (42)
- Safety and efficacy assessment of the HVTN 503/Phambili Study: A double-blind randomized placebo-controlled test-of-concept study of a Clade B-based HIV-1 vaccine in South Africa (2011) (42)
- Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines. (1997) (42)
- Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection (2016) (42)
- Correlation between Interferon-γ Secretion and Cytotoxicity, in Virus-Specific Memory T Cells (2004) (41)
- HIV-1 Single-Stranded RNA Induces CXCL13 Secretion in Human Monocytes via TLR7 Activation and Plasmacytoid Dendritic Cell–Derived Type I IFN (2015) (41)
- OMIP‐014: Validated multifunctional characterization of antigen‐specific human T cells by intracellular cytokine staining (2012) (41)
- HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. (1999) (41)
- Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial. (2011) (41)
- Host genetic polymorphisms associated with innate immune factors and HIV-1. (2011) (41)
- Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons. (2001) (40)
- Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure. (1997) (40)
- HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders (2015) (40)
- Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans (2011) (40)
- Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations (2017) (39)
- HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1 (2013) (39)
- HIV type 1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy. (1997) (38)
- Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. (2004) (38)
- Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa (2019) (38)
- Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects (2021) (38)
- Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials (2016) (37)
- Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. (2004) (37)
- Administration of recombinant interleukin-2 reduces the local parasite load of patients with disseminated cutaneous leishmaniasis. (1990) (37)
- Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. (1994) (37)
- Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method. (1994) (37)
- Trivalent Adenovirus Type 5 HIV Recombinant Vaccine Primes for Modest Cytotoxic Capacity That Is Greatest in Humans with Protective HLA Class I Alleles (2011) (37)
- Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells. (2003) (37)
- Vpu-Deficient HIV Strains Stimulate Innate Immune Signaling Responses in Target Cells (2012) (36)
- HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities (2014) (36)
- BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults. (2019) (36)
- HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation. (1997) (34)
- Cellular immune responses to HIV-1. (1998) (34)
- Human CD1a Deficiency Is Common and Genetically Regulated (2013) (34)
- Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic. (2007) (33)
- A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine (2017) (33)
- MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load (2012) (33)
- Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans. (2014) (32)
- In situ detection of Gag-specific CD8+ cells in the GI tract of SIV infected Rhesus macaques (2010) (32)
- HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine (2017) (32)
- Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina. (1995) (32)
- The Inner Foreskin of Healthy Males at Risk of HIV Infection Harbors Epithelial CD4+ CCR5+ Cells and Has Features of an Inflamed Epidermal Barrier (2014) (31)
- Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells. (2012) (31)
- Absence of Immunodominant Anti-Gag p17 (SL9) Responses among Gag CTL-Positive, HIV-Uninfected Vaccine Recipients Expressing the HLA-A*0201 Allele1 (2004) (31)
- Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial (2018) (30)
- HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial. (2014) (30)
- Immune responses to HIV vaccines and potential impact on control of acute HIV-1 infection. (2010) (29)
- Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cells. (2004) (29)
- Ex Vivo Comparison of Microbicide Efficacies for Preventing HIV-1 Genomic Integration in Intraepithelial Vaginal Cells (2009) (28)
- RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial (2017) (28)
- Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. (1998) (28)
- Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial (2018) (28)
- Human immunodeficiency virus-specific and CD3-redirected cytotoxic T lymphocyte activity in the human female reproductive tract: lack of correlation between mucosa and peripheral blood. (2001) (28)
- DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA (2017) (28)
- A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (2021) (28)
- Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case–control study (2011) (27)
- A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa (2020) (27)
- A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents. (2015) (27)
- Identification and visualization of multidimensional antigen‐specific T‐cell populations in polychromatic cytometry data (2015) (27)
- CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition. (2001) (26)
- Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms (2005) (26)
- Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial (2019) (26)
- The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection (2016) (26)
- Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults (2017) (26)
- Broadly Increased Sensitivity to Cytotoxic T Lymphocytes Resulting from Nef Epitope Escape Mutations 1 (2003) (25)
- Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study (2020) (25)
- Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1. (2012) (25)
- Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials (2015) (25)
- HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. (2007) (24)
- Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination (2012) (24)
- Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. (2011) (24)
- OMIP‐025: Evaluation of human T‐ and NK‐cell responses including memory and follicular helper phenotype by intracellular cytokine staining (2015) (24)
- Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine (2019) (24)
- Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence (2021) (24)
- Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy. (2001) (23)
- HIV vaccines: mosaic approach to virus diversity (2010) (23)
- Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. (2016) (23)
- Robust antibody and cellular responses induced by DNA-only vaccination for HIV. (2020) (23)
- Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection (2006) (22)
- Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines (2020) (22)
- T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents (2015) (22)
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study (2014) (22)
- OMIP‐024: Pan‐leukocyte immunophenotypic characterization of PBMC subsets in human samples (2014) (22)
- Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. (1996) (21)
- Rank-based two-sample tests for paired data with missing values. (2018) (21)
- Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials (2008) (21)
- Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. (1997) (21)
- DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial (2019) (20)
- Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy (2017) (20)
- Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. (2015) (20)
- Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial (2019) (20)
- Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group. (1996) (20)
- Vaccine-Induced HIV-Specific CD8+ T Cells Utilize Preferential HLA Alleles and Target-Specific Regions of HIV-1 (2011) (19)
- Interleukin‐2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection (2006) (19)
- Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells (2019) (19)
- Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals. (1990) (19)
- A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group. (2000) (18)
- Increased Sequence Coverage through Combined Targeting of Variant and Conserved Epitopes Correlates with Control of HIV Replication (2013) (18)
- Demonstration of alpha 1-antitrypsin by immunofluorescence on paraffin-embedded hepatic and pancreatic tissue. (1979) (18)
- Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure. (1999) (18)
- Optimization of a whole blood phenotyping assay for enumeration of peripheral blood leukocyte populations in multicenter clinical trials. (2014) (17)
- Role of Human Immunodeficiency Virus (HIV)-Specific T-Cell Immunity in Control of Dual HIV-1 and HIV-2 Infection (2007) (17)
- Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal. (2014) (17)
- Most CD4+ T cells from human immunodeficiency virus-1 infected patients can undergo prolonged clonal expansion. (1989) (17)
- Vaccination induces HIV broadly neutralizing antibody precursors in humans (2022) (17)
- Hepatitis C virus-specific cytolytic T cell responses after antiviral therapy. (2003) (17)
- Novel Cytotoxic T-Lymphocyte Escape Mutation by a Three-Amino-Acid Insertion in the Human Immunodeficiency Virus Type 1 p6Pol and p6Gag Late Domain Associated with Drug Resistance (2007) (17)
- OMIP‐056: Evaluation of Human Conventional T Cells, Donor‐Unrestricted T Cells, and NK Cells Including Memory Phenotype by Intracellular Cytokine Staining (2019) (17)
- Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice (1990) (17)
- Profiling immunity to HIV vaccines with systems biology. (2012) (16)
- Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1 (1994) (16)
- Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons. (2015) (16)
- Standing guard at the mucosa. (2011) (16)
- T cell responses generated by HIV vaccines in clinical trials (2008) (16)
- Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa (2021) (16)
- Adjuvants: tailoring humoral immune responses (2017) (16)
- Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk (2021) (15)
- Progress in HIV-1 vaccine development (2013) (15)
- In Men at Risk of HIV Infection, IgM, IgG1, IgG3 and IgA Reach the Human Foreskin Epidermis (2015) (15)
- Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector (2019) (15)
- Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1 (2017) (15)
- Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. (2013) (15)
- Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans (2020) (15)
- HIV Vaccine Trials Network: activities and achievements of the first decade and beyond. (2012) (15)
- Association Between Peripheral γδ T-Cell Profile and Disease Progression in Individuals Infected With HIV-1 or HIV-2 in West Africa (2011) (14)
- Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein (2020) (14)
- Selection of HIV vaccine candidates for concurrent testing in an efficacy trial. (2016) (14)
- Enumeration of major peripheral blood leukocyte populations for multicenter clinical trials using a whole blood phenotyping assay. (2012) (13)
- Heme binding to Leishmania mexicana amazonensis. (1988) (13)
- Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group. (1998) (13)
- Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection (2016) (13)
- A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity (2012) (13)
- Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells. (2014) (12)
- HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens (2020) (12)
- Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial (2022) (12)
- A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial. (2016) (12)
- Two new monoclonal antibodies for biochemical and flow cytometric analyses of human interferon regulatory factor-3 activation, turnover, and depletion. (2013) (11)
- The pharmacology of orally administered ciprofloxacin. (1985) (11)
- OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial (2009) (11)
- Preinfection Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T Lymphocytes Failed To Prevent HIV Type 1 Infection from Strains Genetically Unrelated to Viruses in Long-Term Exposed Partners (2009) (11)
- Cryopreservation of Human Mucosal Leukocytes (2016) (11)
- Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation (2021) (11)
- Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation (2021) (11)
- Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial (2019) (11)
- HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipients. (1994) (10)
- CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression. (2006) (10)
- Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice (2016) (9)
- Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release (2021) (9)
- Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials. (2018) (9)
- Distinct populations of antigen-specific tissue-resident CD8+ T cells in human cervix mucosa (2021) (9)
- Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants (2014) (9)
- Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants. (2009) (9)
- Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials. (2017) (8)
- Towards prediction of degenerate CTL epitope recognition (2008) (8)
- EBV-Specific Donor Cells Transduced to Express a High-Affinity WT1 TCR Can Prevent Recurrence in Post-HCT Patients with High-Risk AML (2016) (8)
- Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. (1993) (8)
- Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies (2020) (8)
- Specific activation strategies for amplification of low CTL signals. (1992) (8)
- OMIP‐064: A 27‐Color Flow Cytometry Panel to Detect and Characterize Human NK Cells and Other Innate Lymphoid Cell Subsets, MAIT Cells, and γδ T Cells (2020) (8)
- Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial Cells (2020) (7)
- Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease. (2004) (7)
- Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials Network. (1994) (7)
- Variants in Host Viral Replication Cycle Genes Are Associated With Heterosexual HIV-1 Acquisition in Africans (2014) (7)
- Cryopreservation of human mucosal tissues (2018) (7)
- Recombinant HIV-1 Glycoprotein 120 Induces Distinct Types of Delayed Hypersensitivity in Persons With or Without Pre-Existing Immunologic Memory1 (2001) (7)
- Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans (2021) (6)
- Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period (2019) (6)
- The local cellular immune response in experimental leishmaniasis. (1987) (6)
- Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection (2020) (6)
- Effect of adjunct hydroxyurea on helper T cell immunity in HIV type 1-infected patients with virological suppression. (2004) (6)
- Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency (2021) (6)
- Human Immunodeficiency Virus – Specific and CD 3-Redirected Cytotoxic T Lymphocyte Activity in the Human Female Reproductive Tract : Lack of Correlation between Mucosa and Peripheral Blood (6)
- Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam. (1988) (5)
- An excess of rare genetic variation in ABCE1 among Yorubans and African-American individuals with HIV-1 (2009) (5)
- Activated PD-1+ CD4 T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART. (2019) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults (2022) (5)
- Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection (2016) (5)
- Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection (2019) (5)
- Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge (2021) (4)
- Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting (2012) (4)
- P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial (2009) (4)
- Systems analysis of immune responses to attenuated P. falciparum malaria sporozoite vaccination reveals excessive inflammatory signatures correlating with impaired immunity (2021) (4)
- Rectal and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge. (2021) (4)
- Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency (2022) (4)
- T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial (2012) (4)
- BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD™ vaccine in SARS-CoV-2 seronegative young Indian adults (2022) (4)
- Correction: Mucosal effects for tenofovir 1% gel (2015) (4)
- Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915) (2019) (4)
- Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection (2022) (4)
- In Situ Staining and Laser Capture Microdissection of Lymph Node Residing SIV Gag-Specific CD8+ T cells—A Tool to Interrogate a Functional Immune Response Ex Vivo (2016) (3)
- Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals. (1994) (3)
- Corrigendum: Protective HIV-specific CD8 + T cells evade T reg cell suppression (2011) (3)
- S / AS 01 E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial (2017) (3)
- Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial (2021) (3)
- Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials (2020) (3)
- Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk. (2022) (3)
- Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults (2019) (3)
- Mucosal Immunity and Vaccines Against Simian Immunodeficiency Virus and Human Immunodeficiency Virus (2015) (3)
- Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate (2022) (3)
- Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals. (2008) (2)
- The Local T Cell Response in Experimental Leishmaniasis (1989) (2)
- Corrigendum: OMIP‐056: Evaluation of Human Conventional T Cells, Donor‐Unrestricted T Cells, and NK Cells Including Memory Phenotype by Intracellular Cytokine Staining (2019) (2)
- Author response: Mucosal effects of tenofovir 1% gel (2015) (2)
- Is an HIV Vaccine Possible? (2012) (2)
- Machine Learning Identifies Ponatinib as a Potent Inhibitor of SARS-CoV2-induced Cytokine Storm (2021) (2)
- Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study (2022) (2)
- Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines (2016) (2)
- CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions (2021) (2)
- A Side-by-side Comparison of T cell Reactivity to Fifty-nine M . tuberculosis Antigens in Diverse Populations from five Continents (2)
- HIV-DNA Priming Alters T Cell Responses (2011) (2)
- Chapter 52 – Mucosal Immunity and Vaccines Against Simian Immunodeficiency Virus and Human Immunodeficiency Virus (2005) (2)
- One shot forward for HIV prevention (2014) (2)
- Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine – An Interim Analysis (2022) (2)
- Vaginal Langerhans cells resist genomic integration of HIV-1 but transmit endocytosed virions to susceptible target cells (39.27) (2009) (1)
- The quest for vaccine-induced immune correlates of protection against tuberculosis (2022) (1)
- Correction: Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure (2012) (1)
- The persistence of memory: defining, engineering, and measuring vaccine durability (2022) (1)
- Persistent serum protein signatures define an inflammatory subset of long COVID (2022) (1)
- Cell free HIV-1 virus can infect inner and outer foreskin polarized explants (2012) (1)
- Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain (2021) (1)
- Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape (cid:1) (2007) (1)
- Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination (2012) (1)
- LB6. Asymptomatic Infection and Duration of Viral Shedding in Symptomatic Breakthrough Infections in a Phase 3 Study of AZD1222 (ChAdOx1 nCoV-19) (2021) (1)
- Dynamics of the CD8+ T cell response to a model of acute viral infection (VIR4P.1017) (2014) (1)
- Recovery Schools Rise to the Challenge: Shifting Alcohol Norms and Behaviors in Youth and Emerging Adults (2017) (1)
- Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial (2021) (1)
- A baseline transcriptional signature associates with clinical malaria risk in RTS,S/AS01-vaccinated African children (2021) (1)
- Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles (2012) (1)
- Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials (2021) (1)
- Co-Administration of HIV Env Protein with DNA and/or NYVAC Vaccines in Humans Results in Earlier and Potent Generation of Anti-Env Antibody Responses (2019) (1)
- AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period. (2021) (1)
- Use of placebos in Phase 1 preventive HIV vaccine clinical trials. (2015) (1)
- Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization (2017) (1)
- Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study (2022) (1)
- Longitudinal immune profiling after radiation-attenuated sporozoite vaccination reveals coordinated immune processes correlated with malaria protection (2022) (1)
- 0A07-01. HIV-specific CD8+ T-cells of vaccinees exhibit proliferative and cytotoxic capacities comparable to those of progressors (2009) (1)
- LibGuides. MLA Citation Guide. H. Newspaper Article from Database. (2012) (0)
- Response to Guo et al.'s Letter to the Editor. (2018) (0)
- LibGuides. Faculty Orientation. Interlibrary Loan. (2010) (0)
- LibGuides. Database Tutorials & Guides. LexisNexis. (2015) (0)
- LibGuides. Policy: TANF (Welfare). Books and Periodicals - Print Resources. (2012) (0)
- LibGuides. Faculty Orientation. Internet Sources. (2010) (0)
- LibGuides. Hydraulic Fracturing (Fracking). News Feeds. (2012) (0)
- LibGuides. Policy: Health Care Reform. Was this guide helpful?. (2012) (0)
- LibGuides. Internet Sources. Telephone Directories. (2011) (0)
- Rapid and systemic innate immune responses to an adenoviral HIV vaccine (45.27) (2009) (0)
- LibGuides. Policy: Health Care Reform. Books and Periodicals - Print Resources. (2012) (0)
- LibGuides. Internet Sources. Science. (2011) (0)
- LibGuides. Past ENG 1510 Readings for the Final Exam - Archive. Home. (2015) (0)
- LibGuides. MLA Citation Guide. F. Magazine Article from Database. (2012) (0)
- LibGuides. What is a Libguide?. What Are LibGuides? . (2011) (0)
- LibGuides. Chautauqua-Cattaraugus Full-Text. Welcome. (2014) (0)
- HLA-F and MHC open conformers cooperate in antigen presentation during the inflammatory response. (2017) (0)
- LibGuides. Chautauqua-Cattaraugus Full-Text. Jamestown, NY. (2014) (0)
- Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge (2022) (0)
- LibGuides. British Literature 1. Middle Ages. (2010) (0)
- HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens (2020) (0)
- Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans (2022) (0)
- Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans (2022) (0)
- Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting (2012) (0)
- LibGuides. Faculty Orientation. Collection Development. (2010) (0)
- P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be? (2009) (0)
- Derived Type I IFN - CellTLR7 Activation and Plasmacytoid Dendritic CXCL13 Secretion in Human Monocytes via HIV-1 Single-Stranded RNA Induces (2015) (0)
- HIV vaccine trials and tribulations. (2008) (0)
- Pharmacokinetic Serum Concentrations of VRC01 Correlate with Prevention of HIV-1 Acquisition (2022) (0)
- LibGuides. Database Tutorials & Guides. EBSCO. (2015) (0)
- Effective Antiviral CD8+T Cells Responses Are Rare in HIVPositive Step & Phambili Study Participants but Are Targeted to Low Entropy Viral Epitopes (2013) (0)
- Immunologic Challenges to HIV Vaccine Design (2007) (0)
- Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming. (2023) (0)
- Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles (2012) (0)
- PrimatesInduced T Cell Responses In Nonhuman Effective TLR Adjuvant for SIV Gag Protein Polyinosinic-Polycytidylic Acid Is the Most (2013) (0)
- Who Subsequently Acquire HIV-1 Infection Responses in HIV Vaccine Trial Participants Virus Type 1 (HIV-1)-Specific T-Cell Induction of Human Immunodeficiency (2012) (0)
- and Mucosal T Cell Immunity in Intramuscularly Can Induce Both Systemic HIV-1 Vaccination Administered (2013) (0)
- Cell free HIV-1 virus can infect inner and outer foreskin polarized explants (2012) (0)
- Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability (2022) (0)
- From the editors (2008) (0)
- Structural Characterization of Immune Responses to HPV Infection and HPV Vaccination (2019) (0)
- LibGuides. Business. Business Resources. (2010) (0)
- Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection. (2023) (0)
- The End of AIDS? The Future of Cure and the Current Reality of HIV in Vulnerable Populations (2015) (0)
- LibGuides. Policy: Police Tactics and Use of Force. Databases. (2015) (0)
- LibGuides. Policy: Child Abuse and Neglect. Home. (2012) (0)
- ARS Accreditation Framework – School Organization (2018) (0)
- POP-UP: University and Community Collaborations Towards Addressing Youth Substance Misuse (2018) (0)
- LibGuides. Policy: Social Security. Was this guide helpful?. (2012) (0)
- 1272. Feasibility and Successful Enrollment in Proof-of-Concept Trials to Assess Safety and Efficacy of a Broadly Neutralizing Monoclonal Antibody, VRC01, to Prevent HIV-1 Acquisitionin in Uninfected Individuals (2019) (0)
- LibGuides. APA Citation Guide. D. Article or Chapter in an Edited Book. (2012) (0)
- T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial (2012) (0)
- P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study (2009) (0)
- THE HIV VACCINE PROBLEM : WHY HAVE PAST APPROACHES TO DEVELOP AN HIV VACCINE FAILED ? (0)
- LibGuides. British Literature 1. Resources by Period. (2010) (0)
- LibGuides. Introduction to Research. Evaluate Sources. (2010) (0)
- Leveraging lessons learned from the COVID-19 pandemic for HIV (2022) (0)
- Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation (2021) (0)
- P14-11. Educating community medical providers about HIV vaccine induced seropositivity (2009) (0)
- Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs (2012) (0)
- LibGuides. Global Studies. Global Villager. (2014) (0)
- testCryopreservation of human mucosal leukocytes (2016) (0)
- LibGuides. Policy and Organization. Databases - General Topic. (2012) (0)
- Neutralizing Antibody to Omicron BA.1, BA.2 and BA.5 in COVID-19 Patients (2022) (0)
- a Lysosome-Dependent Mechanism Regulatory Factor 3 during HIV Infection by Vpu Mediates Depletion of Interferon (2012) (0)
- Ontogeny and Specificities of Mucosal and Blood Human Immunodeficiency Virus Type 1-Specific CD8 Cytotoxic T Lymphocytes (2002) (0)
- P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection (2009) (0)
- LibGuides. Tobacco-Free JCC. Home. (2014) (0)
- LibGuides. Policy: Domestic Violence. Writing/Citing Assistance. (2012) (0)
- LibGuides. Faculty Orientation. Copyright and Fair Use. (2010) (0)
- LibGuides. Library Instruction Evaluation. Home. (2014) (0)
- Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs (2012) (0)
- LibGuides. Policy: Child Abuse and Neglect. Was this guide helpful?. (2012) (0)
- Th2-Biased Transcriptional Profile Predicts HIV Envelope-Specific Polyfunctional CD4+ T Cells That Correlated with Reduced Risk of Infection in RV144 Trial (2022) (0)
- HLA-F and MHC open conformers in a novel HIV-1 immunization strategy (2016) (0)
- LibGuides. Films @ JCC Libraries. National Film Registry. (2013) (0)
- LibGuides. APA Citation Guide. B. Two Authors or Editors. (2012) (0)
- LibGuides. Policy: Social Security. Internet Sources. (2012) (0)
- LibGuides. Contemporary Art. Writing/Citing Assistance. (2011) (0)
- Critical for Immune Control of HIV-1 Restricted by Protective HLA Alleles Is Preservation of T Cell Proliferation (2012) (0)
- LibGuides. Films @ JCC Libraries. American Film Institute. (2013) (0)
- Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8 (cid:1) T Cells Induced by Different Adenovirus Vectors (2013) (0)
- LibGuides. Policy: Megan's Law. Databases. (2012) (0)
- LibGuides. Policy: Minimum Wage. Books and Periodicals - Print Resources. (2012) (0)
- LibGuides. Business. Was This Guide Helpful (2010) (0)
- LibGuides. Contemporary Art. Home. (2011) (0)
- LibGuides. Policy: Poverty. Internet Sources. (2012) (0)
- Visceral Leishmaniasis in Euthymic C57BL/6 eplep Mice (0)
- LibGuides. Internet Sources. Physics. (2011) (0)
- LibGuides. Internet Sources. Statistics. (2011) (0)
- LibGuides. Policy: Medical Marijuana. Was this guide helpful?. (2015) (0)
- Role of Human Immunodeficiency Virus (HIV)-Specific T-Cell Immunity in Control of Dual HIV-1 and HIV-2 Infection (cid:1) (2007) (0)
- LibGuides. APA Citation Guide. A. Electronic Image. (2012) (0)
- LibGuides. Tobacco-Free JCC. In the News. (2014) (0)
- Shared HIV envelope-specific B cell clonotypes induced by a pox-protein vaccine regimen (2021) (0)
- LibGuides. MLA Citation Guide. H. Interview. (2012) (0)
- LibGuides. MLA 8 Citation Guide. Home. (2016) (0)
- LibGuides. MLA Citation Guide. G. Corporate Author. (2012) (0)
- LibGuides. Policy: Medical Marijuana. Internet Sources. (2015) (0)
- LibGuides. Faculty Orientation. Home. (2010) (0)
- LibGuides. Internet Sources. Environment. (2011) (0)
- LibGuides. eBooks. Project Gutenberg. (2013) (0)
- LibGuides. Policy: Medicaid. Books and Periodicals - Print Resources. (2012) (0)
- LibGuides. MLA Citation Guide. K. Edition other than the First. (2012) (0)
- LibGuides. Policy: Police Tactics and Use of Force. Home. (2015) (0)
- LibGuides. MLA Citation Guide. B. Speeches, Lectures, Oral Presentations. (2012) (0)
- LibGuides. Internet Sources. Photos/Multimedia. (2011) (0)
- LibGuides. APA Citation Guide. D. Journal Article with 6 or more Authors. (2012) (0)
- Enhanced immunity tohumanimmunodeficiency virus (HIV) envelope elicited byacombined vaccine regimen consisting ofpriming withavaccinia recombinant expressing HIV envelope andboosting withgpl60protein (1993) (0)
- further consideration, apart from the relationships of pCTL frequencies reported here. (1999) (0)
- LibGuides. Business. Internet Sources. (2010) (0)
- LibGuides. Banned Books Week. Home. (2012) (0)
- LibGuides. Policy: Medicare. Writing/Citing Assistance. (2012) (0)
- LibGuides. Occupational Therapy Assistant. Writing/Citing Assistance. (2011) (0)
- LibGuides. Policy: Education Reform. Was this guide helpful?. (2012) (0)
- Isolation and Characterization of Cross-Neutralizing COVID-19+ Subjects (2021) (0)
- LibGuides. Internet Sources. Travel. (2011) (0)
- LibGuides. Policy: Education Reform. Home. (2012) (0)
- LibGuides. LITERARY CRITICISM. Literary Criticism. (2010) (0)
- P846 Biomarkers of HIV exposure and condomless receptive anal sex in men who have sex with men using self-collected rectal swabs (2019) (0)
- LibGuides. Films @ JCC Libraries. Need Help?. (2013) (0)
- Rapid Collection of Human Rectal Secretions Using OriCol Devices is Suitable for Measurement of Mucosal Immunoglobulins Without Blood Contamination (2021) (0)
- LibGuides. Internet Sources. Communications. (2011) (0)
- LibGuides. Internet Sources. Law. (2011) (0)
- Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization (cid:1) (2009) (0)
- Speci fi city and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modi fi ed Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles (2014) (0)
- Title: Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence Authors: (2021) (0)
- LibGuides. Policy: Drug Abuse. Home. (2012) (0)
- LibGuides. MLA Citation Guide. D. Journal Article from Database. (2012) (0)
- SUPPLEMENTAL METHODS AND EXTENDED DERIVATIONS (2015) (0)
- CD8+ T cell inhibitory activity and targeting of beneficial regions and conserved elements within the HIV proteome. (2015) (0)
- Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens (2022) (0)
- LibGuides. Internet Sources. Biology. (2011) (0)
- Expressing the HLA-A*0201 Allele HIV-Uninfected Vaccine Recipients (SL9) Responses among Gag CTL-Positive, Absence of Immunodominant Anti-Gag p17 (2004) (0)
- Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine (2019) (0)
- LibGuides. Internet Sources. Acronyms. (2011) (0)
- LibGuides. Oral presentations, public speaking, and speeches. Books and Journals. (2011) (0)
- LibGuides. Policy: Health Care Reform. Home. (2012) (0)
- LibGuides. Internet Sources. Film/Cinematography. (2011) (0)
- LibGuides. Policy: Medical Marijuana. Writing/Citing Assistance. (2015) (0)
- LibGuides. Internet Sources. Literature. (2011) (0)
- LibGuides. MLA Citation Guide. N. Translation. (2012) (0)
- LibGuides. MLA Citation Guide. G. Newspaper Article. (2012) (0)
- LibGuides. Researching an Era - 20th Century. Home. (2012) (0)
- LibGuides. Internet Sources. Theatre and Performing Arts. (2011) (0)
- LibGuides. Hydraulic Fracturing (Fracking). Writing/Citing Assistance. (2012) (0)
- Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study. (2022) (0)
- LibGuides. Introduction to Research. Background Information - Encyclopedias. (2010) (0)
- LibGuides. LITERARY CRITICISM. Online Resources. (2010) (0)
- LibGuides. Policy: Poverty. Home. (2012) (0)
- LibGuides. MLA Citation Guide. B. Basic Web Page. (2012) (0)
- Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults (2023) (0)
- The CD38+ HLA-DR+ PD-1+ CD4 T cell population represents a short-lived part of the viral reservoir and predicts poor immunologic recovery upon initiation of ART (2017) (0)
- LibGuides. Policy: Education Reform. Databases. (2012) (0)
- LibGuides. Business. Quick Library Catalog Search. (2010) (0)
- LibGuides. Policy: Minimum Wage. Home. (2012) (0)
- Inflammatory signals control human MAIT cell effector function (2016) (0)
- LibGuides. APA Citation Guide. E. Article in a Reference Book. (2012) (0)
- LibGuides. Policy: Homelessness. Home. (2012) (0)
- MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data (2015) (0)
- D-107 Vaccination establishes CXCR5+PD1+CD4+ peripheral blood germinal center T follicular helper cell relatives in humans (2016) (0)
- LibGuides. Policy: Supplemental Nutrition Assistance Program (SNAP) formerly Food Stamps. Writing/Citing Assistance. (2012) (0)
- LibGuides. MLA Citation Guide. C. Sound Recording. (2012) (0)
- LibGuides. Internet Sources. Local Information. (2011) (0)
- LibGuides. Policy: Drug Abuse. Writing/Citing Assistance. (2012) (0)
- LibGuides. MLA Citation Guide. K. Play. (2012) (0)
- HIV-1 Nucleic Acids Identify Rectal HIV Exposures in Self-Collected Rectal Swabs, Whereas Y-Chromosome Single Tandem Repeat Mixtures Are Not Reliable Biomarkers of Condomless Receptive Anal Intercourse (2021) (0)
- T helper 2 transcriptional profile predicts single-cell HIV envelope-specific polyfunctional CD4+ T cells correlated with reduced risk of infection in RV144 trial (2021) (0)
- LibGuides. Internet Sources. Digital Collections. (2011) (0)
- LibGuides. APA Citation Guide. A. Interview. (2012) (0)
- LibGuides. Campus Health & Safety Resources. Substance Abuse. (2014) (0)
- LibGuides. What is a Libguide?. Video. (2011) (0)
- LibGuides. What is a Libguide?. Information Literacy. (2011) (0)
- LibGuides. What is a Libguide?. Faculty-Librarian Collaboration. (2011) (0)
- Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans (2021) (0)
- Priming CD8 (cid:1) T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8 (cid:1) T cells retaining CD28 (2011) (0)
- LibGuides. Internet Sources. Health/Medicine. (2011) (0)
- LibGuides. Contemporary Art. Databases. (2011) (0)
- LibGuides. MLA Citation Guide. E. Anthology, Collection or Edited Book. (2012) (0)
- LibGuides. Policy and Organization. Home. (2012) (0)
- LibGuides. Oral presentations, public speaking, and speeches. Was this guide helpful?. (2011) (0)
- LibGuides. Policy: Prison and Sentencing. Was this guide helpful?. (2012) (0)
- First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study (2022) (0)
- LibGuides. APA Citation Guide. C. Audio Podcast. (2012) (0)
- LibGuides. Internet Sources. U. (2011) (0)
- Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine‐induced T‐cell responses (2022) (0)
- LibGuides. MLA Citation Guide. Books. (2012) (0)
- LibGuides. Faculty Orientation. Chautauqua Room. (2010) (0)
- LibGuides. Policy: Social Security. Home. (2012) (0)
- Validation of an automated gating pipeline for ICS assays in vaccine trials (2017) (0)
- LibGuides. MLA Citation Guide. Periodical Articles. (2012) (0)
- + ligands together enhances generation of CD8 T-cells with dendritic cells matured using TLR4 and TLR7/8 + (2011) (0)
- LibGuides. Faculty Orientation. JCC Archives. (2010) (0)
- LibGuides. Business. Databases. (2010) (0)
- Progress in the development of a preventive HIV-1 vaccine. (2002) (0)
- LibGuides. APA Citation Guide. G. E-Book. (2012) (0)
- LibGuides. Faculty Orientation. Library Computers. (2010) (0)
- Oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis increases expression of type I/III interferon-stimulated factors in the gastrointestinal tract but not in the blood (2019) (0)
- LibGuides. APA Citation Guide. Websites. (2012) (0)
- LibGuides. Occupational Therapy Assistant. Searching the Catalog and Using Subject Headings. (2011) (0)
- LibGuides. APA Citation Guide. E. Entry in a Reference Work. (2012) (0)
- LibGuides. Policy: Domestic Violence. Home. (2012) (0)
- COVID-19 vaccination and HIV-1 acquisition – Authors’ reply (2022) (0)
- LibGuides. What is a Libguide?. LibGuides & Students. (2011) (0)
- LibGuides. What is a Libguide?. Widgets. (2011) (0)
- 1 testCryopreservation of human mucosal leukocytes (2016) (0)
- LibGuides. ENG1510 - Readings for the Final Exam (Fall 2014). Home. (2011) (0)
- Correction: Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1 (2019) (0)
- LibGuides. Internet Sources. College. (2011) (0)
- LibGuides. Policy: Prison and Sentencing. Home. (2012) (0)
- LibGuides. Policy: Adoption. Home. (2012) (0)
- LibGuides. MLA Citation Guide. E. Scripture. (2012) (0)
- LibGuides. Policy and Organization. Internet Sources. (2012) (0)
- LibGuides. Policy: Social Security. Books and Periodicals - Print Resources. (2012) (0)
- LibGuides. Policy: Poverty. Writing/Citing Assistance. (2012) (0)
- LibGuides. Policy: Megan's Law. Home. (2012) (0)
- LibGuides. Policy: Child Health Plus. Home. (2012) (0)
- LibGuides. Sustainability and Green Energy. Home. (2012) (0)
- LibGuides. LITERARY CRITICISM. Historical Context. (2010) (0)
- LibGuides. Chautauqua-Cattaraugus Full-Text. Cattaraugus County. (2014) (0)
- LibGuides. Internet Sources. Business. (2011) (0)
- LibGuides. Chautauqua-Cattaraugus Full-Text. Index. (2014) (0)
- LibGuides. Policy: Child Health Plus. Books and Periodicals - Print Resources. (2012) (0)
- Multivariate linear regression models to investigate associations between beneficial responses, entropy, HLA alleles and % inhibition (dependent variable). (2015) (0)
- Author response: Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study (2021) (0)
- LibGuides. APA Citation Guide. F. No Author. (2012) (0)
- LibGuides. Policy: Health Care Reform. Writing/Citing Assistance. (2012) (0)
- LibGuides. Emergency Preparedness. National and Local Resources. (2013) (0)
- Rapid Collection of Human Rectal Secretions Using OriCol Devices Is Suitable for Measurement of Mucosal Ig without Blood Contamination (2020) (0)
- LibGuides. MLA Citation Guide. Works of Art. (2012) (0)
- An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus (2018) (0)
- 175 HIV-1 Evolution in Primary Infection is Affected by Stochastic Followed by Selective Processes (2011) (0)
- LibGuides. What is a Libguide?. Library Instruction. (2011) (0)
- LibGuides. Business. International Business. (2010) (0)
- LibGuides. LITERARY CRITICISM. Shakespeare. (2010) (0)
- Infection Critical for Immune Control of HIV-1 Restricted by Protective HLA Alleles Is Preservation of T Cell Proliferation (2006) (0)
This paper list is powered by the following services:
Other Resources About Julie McElrath
What Schools Are Affiliated With Julie McElrath?
Julie McElrath is affiliated with the following schools:
